Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2025, Quick Ratio deteriorated to 32.71 above company average Quick Ratio.

Within Medical Equipment & Supplies industry only one company has achieved higher Quick Ratio in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from to 79.

Explain Quick Ratio?
How much Cash & cash equivalents MINE�s has?
What are MINE�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MINE Quick Ratio	(Dec 31 2025) Q4	0 Q3	0 Q2	0 Q1	(Jan 31 2016) Q2
Y / Y Current Liabilities Change	-83.24 %	-82.04 %	-85.14 %	-65.57 %	95.71 %
Y / Y Cash & cash equivalent Change	11070619.71 %	13592064.77 %	526132.89 %	27645.96 %	-99.41 %
Quick Ratio MRQ	32.71	32.71	32.71	32.71	0
MINE's Total Ranking	# 79	#	#	#	#
Seq. Current Liabilities Change	0 %	0 %	0 %	-83.24 %	7.19 %
Seq. Cash & cash equivalent Change	0 %	0 %	0 %	11070619.71 %	22.78 %

Quick Ratio fourth quarter 2025 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 2
Healthcare Sector	# 19
Overall Market	# 79

Quick Ratio Statistics
High	Average	Low
32.71	8.2	0
(Dec 31 2025)		(Oct 31 2015)

Financial Statements
Mayfair Gold 's Current Liabilities	$ 1 Millions	Visit MINE's Balance sheet
Mayfair Gold 's Cash & cash equivalent	$ 38 Millions	Visit MINE's Balance sheet
Source of MINE's Sales		Visit MINE's Sales by Geography

Cumulative Mayfair Gold 's Quick Ratio

MINE's Quick Ratio for the trailling 12 Months

MINE Quick Ratio	(Dec 31 2025) 12 Months	0 12 Months	0 12 Months	0 12 Months	(Jan 31 2016) 12 Months
Y / Y Current Liabilities TTM Growth	-81.1 %	-50.86 %	-5.1 %	47.54 %	81.09 %
Y / Y Cash & cash equivalent TTM Growth	104871.78 %	56198.88 %	14956.45 %	4728.03 %	-78.54 %
Quick Ratio TTM	32.71	10.94	4.83	1.7	0.01
Total Ranking TTM	# 3868	#	#	#	#
Seq. Current Liabilities TTM Growth	-55.4 %	-33.75 %	-29.74 %	-9 %	15.99 %
Seq. Cash & cash equivalent TTM Growth	33.33 %	50 %	99.96 %	26148.36 %	-28.49 %

Quick ratio ranking by company, industry and sector >> Back to MINE Financial Strength Comparisons >> Go to Compare MINE Quick Ratio to its Competitors

On the trailing twelve months basis MINE Cash & cash equivalent more than doubled by 11070619.71 % in Q4 2025 year on year, while Current Liabilities remained unchanged to $1 millions, this led to increase in in Mayfair Gold 's Quick Ratio to 32.71, above MINE average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry just one company has achieved higher Quick Ratio during the twelve months ending in the Dec 31 2025. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from to 3868.

Explain Quick Ratio?
How much Cash & cash equivalents MINE�s has?
What are MINE�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 2
Healthcare Sector	# 19
Within the Market	# 3868

trailing twelve months Quick Ratio Statistics
High	Average	Low
32.71	8.2	0
(Dec 31 2025)		(Oct 31 2015)

Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry	Quick Ratio	Dec 31 2025 MRQ Cash & cash equivalent	Dec 31 2025 MRQ Current Liabilities
Utah Medical Products Inc	33.01	$ 85.756 Millions	$ 2.598 Millions
Mayfair Gold Corp	32.71	$ 38.194 Millions	$ 1.168 Millions
Microbot Medical Inc	25.39	$ 79.329 Millions	$ 3.125 Millions
Fractyl Health Inc	25.04	$ 81.540 Millions	$ 3.256 Millions
Valion Bio Inc	19.57	$ 12.645 Millions	$ 0.646 Millions
Vivos Inc	16.85	$ 1.559 Millions	$ 0.092 Millions
Modular Medical Inc	15.55	$ 13.095 Millions	$ 0.842 Millions
Safe Pro Group Inc	14.27	$ 16.793 Millions	$ 1.177 Millions
Envveno Medical Corporation	13.30	$ 28.212 Millions	$ 2.122 Millions
Bone Biologics Corporation	12.76	$ 5.334 Millions	$ 0.418 Millions
Talkspace Inc	10.89	$ 92.586 Millions	$ 8.501 Millions
Pulse Biosciences Inc	10.19	$ 80.735 Millions	$ 7.923 Millions
Alpha Tau Medical Ltd	10.05	$ 76.903 Millions	$ 7.652 Millions
Rxsight Inc	9.92	$ 228.128 Millions	$ 22.991 Millions
Lemaitre Vascular Inc	9.89	$ 359.120 Millions	$ 36.323 Millions
Profound Medical Corp	9.83	$ 59.723 Millions	$ 6.075 Millions
Logicmark Inc	9.08	$ 15.368 Millions	$ 1.692 Millions
Ceribell Inc	8.86	$ 159.261 Millions	$ 17.984 Millions
Bluejay Diagnostics Inc	8.65	$ 5.165 Millions	$ 0.597 Millions
Delcath Systems Inc	8.39	$ 91.036 Millions	$ 10.849 Millions
Sight Sciences Inc	8.34	$ 91.965 Millions	$ 11.027 Millions
Carlsmed Inc	7.69	$ 109.793 Millions	$ 14.280 Millions
EBR Systems, Inc.	7.57	$ 101.595 Millions	$ 13.422 Millions
Inmode Ltd	7.16	$ 555.244 Millions	$ 77.569 Millions
Beta Bionics Inc	7.09	$ 219.125 Millions	$ 30.924 Millions
Orchestra Biomed Holdings Inc	6.66	$ 106.512 Millions	$ 15.985 Millions

Date modified: 2026-07-07T12:13:25+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.